148 related articles for article (PubMed ID: 12707700)
1. [Heparin during acute ischemic stroke. Present data and clinical situation].
Daffertshofer M; Grips E; Dempfle CE; Hennerici M
Nervenarzt; 2003 Apr; 74(4):307-19. PubMed ID: 12707700
[TBL] [Abstract][Full Text] [Related]
2. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
3. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
5. Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke.
Padma V; Fisher M; Moonis M
Expert Rev Cardiovasc Ther; 2006 May; 4(3):405-15. PubMed ID: 16716101
[TBL] [Abstract][Full Text] [Related]
6. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation in acute ischaemic stroke: deep vein thrombosis prevention and long-term stroke outcomes.
Lensing AW
Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S123-7. PubMed ID: 10493241
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
Prandoni P; Simioni P; Pagnan A
Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
[TBL] [Abstract][Full Text] [Related]
10. [Heparin therapy in embolic cerebral infarct. A retrospective study].
Kunze I; Glahn J; Busse O
Nervenarzt; 1991 Aug; 62(8):477-82. PubMed ID: 1944711
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
Prandoni P; Carnovali M; Marchiori A;
Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.
Vergouwen MD; Roos YB; Kamphuisen PW
Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676
[TBL] [Abstract][Full Text] [Related]
13. [Initial results of the PROTECT Study publicized. Stroke patients need effective thrombosis prevention].
Diener HC
MMW Fortschr Med; 2005 Jun; 147(22):50. PubMed ID: 15977636
[No Abstract] [Full Text] [Related]
14. Prevention of venous thromboembolism, recurrent stroke, and other vascular events after acute ischemic stroke: the role of low-molecular-weight heparin and antiplatelet therapy.
Sherman DG
J Stroke Cerebrovasc Dis; 2006; 15(6):250-9. PubMed ID: 17904084
[TBL] [Abstract][Full Text] [Related]
15. Thromboprophylaxis and early antithrombotic therapy in patients with acute ischemic stroke and cerebral venous and sinus thrombosis.
Busch M; Masuhr F
Eur J Med Res; 2004 Apr; 9(4):199-206. PubMed ID: 15210400
[TBL] [Abstract][Full Text] [Related]
16. Therapy of acute thromboembolism with heparin and warfarin.
Carter BL
Clin Pharm; 1991 Jul; 10(7):503-18. PubMed ID: 1860301
[TBL] [Abstract][Full Text] [Related]
17. Dalteparin: new indication. Prophylaxis in medical patients: no advance.
Prescrire Int; 2005 Feb; 14(75):14-5. PubMed ID: 15751168
[TBL] [Abstract][Full Text] [Related]
18. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
[TBL] [Abstract][Full Text] [Related]
19. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
20. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
